News Daily News FDA: Class I Recall for Cook Medical’s CrossCath Support Catheters L.A. McKeown December 17, 2019
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Daily News FDA: New Concerns Surface With Endologix Grafts for AAA L.A. McKeown October 28, 2019
News Daily News Burst Balloons With Sapien 3 Ultra Prompt ‘Urgent Field Safety Notice’ and Canadian Recall Shelley Wood July 22, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2019 Caitlin E. Cox May 31, 2019
News Daily News FDA Provides Update on Poorer Survival With Impella RP in Postmarket Setting Todd Neale May 21, 2019
News Daily News FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors Michael O'Riordan May 08, 2019
News Daily News FDA Warns of Cybersecurity Vulnerabilities With Some Medtronic Implanted Devices Michael O'Riordan March 22, 2019
News Daily News FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients L.A. McKeown March 21, 2019
News Daily News FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD L.A. McKeown March 15, 2019
News Daily News FDA Provides Update on Tainted ARB Investigation, With New Impurity Found Todd Neale March 04, 2019
News Daily News FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat Shelley Wood February 22, 2019
News Daily News Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons L.A. McKeown February 19, 2019
News Daily News FDA Warns Healthcare Providers of Potential Rise in Death Rate With Impella RP Caitlin E. Cox February 04, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2019 Caitlin E. Cox January 31, 2019
News Conference News ISET 2019 Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched Caitlin E. Cox January 28, 2019
News Daily News FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD Michael O'Riordan January 17, 2019